Skip to Content


In the US, Zoladex (goserelin systemic) is a member of the following drug classes: gonadotropin releasing hormones, hormones/antineoplastics and is used to treat Bleeding Disorder, Breast Cancer - Palliative, Endometriosis and Prostate Cancer.

US matches:

UK matches:

Ingredient matches for Zoladex


Goserelin is reported as an ingredient of Zoladex in the following countries:

  • Ecuador
  • Egypt
  • Latvia
  • Peru
  • Philippines
  • Poland
  • Taiwan
  • Tunisia

Goserelin acetate (a derivative of Goserelin) is reported as an ingredient of Zoladex in the following countries:

  • Argentina
  • Belgium
  • Brazil
  • Bulgaria
  • Canada
  • China
  • Colombia
  • Croatia (Hrvatska)
  • Cyprus
  • Denmark
  • Estonia
  • Finland
  • France
  • Georgia
  • Greece
  • Hong Kong
  • Iceland
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Kuwait
  • Lithuania
  • Malaysia
  • Malta
  • Mexico
  • Netherlands
  • Norway
  • Portugal
  • Romania
  • Serbia
  • Singapore
  • South Africa
  • Spain
  • Sweden
  • Thailand
  • United Kingdom
  • United States
  • Uruguay
  • Vietnam

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.